UTHR.NASDAQUnited Therapeutics CORP
Form 4: UNITED THERAPEUTICS CEO Sells Shares
Sentiment:
Insider Transaction (Form 4)
Martine A Rothblatt, Chairperson & CEO and a Director of UNITED THERAPEUTICS Corp, sold 9,500 shares of common stock on August 7, 2026.
Summary
- Option exercise/conversion: acquired 9,500 Common Stock at $135.42 ($1,286,490) on August 7, 2026; holds 333,943 after (Indirect).
- Open-market sale: disposed of 357 Common Stock at $525.29 ($187,527) on August 7, 2026; holds 333,586 after (Indirect).
- Open-market sale: disposed of 1,112 Common Stock at $526.15 ($585,077) on August 7, 2026; holds 332,474 after (Indirect).
- Open-market sale: disposed of 411 Common Stock at $526.82 ($216,521) on August 7, 2026; holds 332,063 after (Indirect).
- Open-market sale: disposed of 240 Common Stock at $527.72 ($126,652) on August 7, 2026; holds 331,823 after (Indirect).
- Open-market sale: disposed of 709 Common Stock at $529.14 ($375,158) on August 7, 2026; holds 331,114 after (Indirect).
- Open-market sale: disposed of 1,450 Common Stock at $530.32 ($768,959) on August 7, 2026; holds 329,664 after (Indirect).
- Open-market sale: disposed of 2,781 Common Stock at $531.30 ($1,477,558) on August 7, 2026; holds 326,883 after (Indirect).
- Open-market sale: disposed of 183 Common Stock at $532.01 ($97,358) on August 7, 2026; holds 326,700 after (Indirect).
- Open-market sale: disposed of 160 Common Stock at $533.37 ($85,339) on August 7, 2026; holds 326,540 after (Indirect).
- Open-market sale: disposed of 200 Common Stock at $534.27 ($106,853) on August 7, 2026; holds 326,340 after (Indirect).
- Open-market sale: disposed of 160 Common Stock at $535.31 ($85,649) on August 7, 2026; holds 326,180 after (Indirect).
- Open-market sale: disposed of 360 Common Stock at $536.99 ($193,318) on August 7, 2026; holds 325,820 after (Indirect).
- Open-market sale: disposed of 625 Common Stock at $538.54 ($336,590) on August 7, 2026; holds 325,195 after (Indirect).
- Open-market sale: disposed of 632 Common Stock at $539.14 ($340,738) on August 7, 2026; holds 324,563 after (Indirect).
- Open-market sale: disposed of 120 Common Stock at $540.32 ($64,838) on August 7, 2026; holds 324,443 after (Indirect).
- Option exercise/conversion: disposed of 9,500 Stock Option on August 7, 2026; holds 179,910 after (Indirect).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $5,048,137 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Martine A Rothblatt — Director, Officer (Chairperson & CEO)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-07 | Option exercise/conversion | Common Stock | 9,500 | $135 | $1.3M | 333,943 |
| 2026-08-07 | Open-market sale | Common Stock | 357 | $525 | $187.5K | 333,586 |
| 2026-08-07 | Open-market sale | Common Stock | 1,112 | $526 | $585.1K | 332,474 |
| 2026-08-07 | Open-market sale | Common Stock | 411 | $527 | $216.5K | 332,063 |
| 2026-08-07 | Open-market sale | Common Stock | 240 | $528 | $126.7K | 331,823 |
| 2026-08-07 | Open-market sale | Common Stock | 709 | $529 | $375.2K | 331,114 |
| 2026-08-07 | Open-market sale | Common Stock | 1,450 | $530 | $769.0K | 329,664 |
| 2026-08-07 | Open-market sale | Common Stock | 2,781 | $531 | $1.5M | 326,883 |
| 2026-08-07 | Open-market sale | Common Stock | 183 | $532 | $97.4K | 326,700 |
| 2026-08-07 | Open-market sale | Common Stock | 160 | $533 | $85.3K | 326,540 |
| 2026-08-07 | Open-market sale | Common Stock | 200 | $534 | $106.9K | 326,340 |
| 2026-08-07 | Open-market sale | Common Stock | 160 | $535 | $85.6K | 326,180 |
| 2026-08-07 | Open-market sale | Common Stock | 360 | $537 | $193.3K | 325,820 |
| 2026-08-07 | Open-market sale | Common Stock | 625 | $539 | $336.6K | 325,195 |
| 2026-08-07 | Open-market sale | Common Stock | 632 | $539 | $340.7K | 324,563 |
| 2026-08-07 | Open-market sale | Common Stock | 120 | $540 | $64.8K | 324,443 |
| 2026-08-07 | Option exercise/conversion | Stock Option | 9,500 | — | — | 179,910 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-07 | Option exercise/conversion (9,500 shares) |
| 2026-08-07 | Open-market sale (357 shares) |
| 2026-08-07 | Open-market sale (1,112 shares) |
| 2026-08-07 | Open-market sale (411 shares) |
| 2026-08-07 | Open-market sale (240 shares) |
| 2026-08-07 | Open-market sale (709 shares) |
| 2026-08-07 | Open-market sale (1,450 shares) |
| 2026-08-07 | Open-market sale (2,781 shares) |
| 2026-08-07 | Open-market sale (183 shares) |
| 2026-08-07 | Open-market sale (160 shares) |
| 2026-08-07 | Open-market sale (200 shares) |
| 2026-08-07 | Open-market sale (160 shares) |
| 2026-08-07 | Open-market sale (360 shares) |
| 2026-08-07 | Open-market sale (625 shares) |
| 2026-08-07 | Open-market sale (632 shares) |
| 2026-08-07 | Open-market sale (120 shares) |
| 2026-08-07 | Option exercise/conversion (9,500 shares) |
Keywords
insider transaction, Form 4, UTHR, UNITED THERAPEUTICS Corp, bearish, Martine A Rothblatt
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.